Pharmaceutical Manufacturing Equipment Market

Pharmaceutical Manufacturing Equipment Market Size, Share, Growth Analysis, By Equipment Type:(Packaging Machines, Mixing and Blending Machines), By End-product Type:(Solid, Liquid), By Region(North America, US) - Industry Forecast 2024-2031

Report ID: UCMIG35J2138 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Pharmaceutical Manufacturing Equipment Market Insights

Market Overview:

The market for pharmaceutical manufacturing equipment is anticipated to reach a value of USD 19.7 billion by 2028, from an estimated USD 14.5 billion in 2023, at a CAGR of 6.3%. High growth in the pharmaceutical and biopharmaceutical industries as well as technological advancements are key market drivers.

Pharmaceutical Manufacturing Equipment Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
GET FREE SAMPLE

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Life Sciences Tools & Services by segment aggregation, the contribution of the Life Sciences Tools & Services in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

Segmentation Analysis:

The Pharmaceutical Manufacturing Equipment Market is segmented by Equipment Type:, End-product Type:, Region. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.

Pharmaceutical Manufacturing Equipment Market Basis Point Share Analysis, 2021 Vs. 2028
BasisPointShareAnalysis
To get detailed analysis on all segments
BUY NOW
  • Based on Equipment Type: the market is segmented as, Packaging Machines, Mixing and Blending Machines, Filling Machines, Spray Drying Equipment, Milling Equipment, Inspection Equipment, Extrusion Equipment, Tablet Compression Presses
  • Based on End-product Type: the market is segmented as, Solid, Liquid
  • Based on Region the market is segmented as, North America, US, Canada, Mexico, Europe, Germany, UK, France, Italy, Rest of Europe, Asia Pacific, China, Japan, India, South Korea, Rest of Asia Pacific, Rest of the World, Middle East & Africa, South America, KEY MARKET PLAYERS, GEA Group Aktiengesellschaft, I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A, Syntegon Technology GmbH, ACG, Thermo Fisher Scientific Inc.

Regional Analysis:

Pharmaceutical Manufacturing Equipment Market is being analyzed by North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA) regions. Key countries including the U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, and South Africa among others were analyzed considering various micro and macro trends.

Pharmaceutical Manufacturing Equipment Market Attractiveness Analysis, By Region 2020-2028
AttractivenessAnalysis
To know more about the market opportunities by region and country, click here to
REQUEST FREE CUSTOMIZATION

Pharmaceutical Manufacturing Equipment Market : Risk Analysis

SkyQuest's expert analysts have conducted a risk analysis to understand the impact of external extremities on Pharmaceutical Manufacturing Equipment Market. We analyzed how geopolitical influence, natural disasters, climate change, legal scenario, economic impact, trade & economic policies, social & ethnic concerns, and demographic changes might affect Pharmaceutical Manufacturing Equipment Market's supply chain, distribution, and total revenue growth.

Competitive landscaping:

To understand the competitive landscape, we are analyzing key Pharmaceutical Manufacturing Equipment Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the Pharmaceutical Manufacturing Equipment Market.

To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.

Key Players Covered in the Report:

  • eutical manufacturing equipment market is estimated to be worth USD 14.5 billion in 2023 and is projected to reach USD 19.7 billion by 2028, at a CAGR of 6.3% during the forecast period. Growing global demand for generics, rising necessity for adoption of flexible pharmaceutical manufacturing practices, rising potential of pharmaceutical manufacturing infrastructure worldwide, and growing implementation of government schemes and regulatory frameworks for quality assurance are some of the major factors driving the market growth globally.
  • Pharmaceutical Manufacturing Equipment Market Dynamics
  • Driver: Rising demand for generics
  • As patents on branded drugs are expiring, the generic drug market is proliferating worldwide. One of the major factors driving the generic drug market is the implementation of favorable policy frameworks across regions aimed at reducing the overall cost of healthcare and check the spread of chronic diseases. In a time when pharmaceutical manufacturers are experiencing stagnation in developed economies, the growth opportunities in emerging markets, especially in Africa, seem enormous. Significant factors contributing to these opportunities include critical infrastructure improvements, extensive urbanization, rising demand for a diverse set of medications from the population, and growing investments in the healthcare sector. Moreover, there is a growing inclination toward injectable generics. Governments across the world are supporting the manufacturing of injectable generics as they offer benefits in terms of dosage, quality, strength, and less cost-intensive R&D cycle. Even in developed economies such as the US, the growing aging population, the expiration of patents for many popular drugs, and an exponential rise in chronic diseases are contributing to the growth of the generics market.
  • Restraint: Demand for refurbished equipment
  • For manufacturers to purchase and install new manufacturing equipment, many upfront costs are involved. In addition, manufacturing equipment can rapidly become outdated in a dynamic industry such as pharmaceuticals. Therefore, there is a growing demand for refurbished pharmaceutical manufacturing equipment across the globe. Refurbishment can be described as rebuilding or updating used equipment with new materials, technology, components, or parts to restore its condition to its original operating state and appearance. Moreover, refurbishment typically costs around half as much as acquiring new equipment. Therefore, refurbished manufacturing equipment helps the manufacturer by reducing upfront costs, providing flexibility for upgradation, and lessening costs by extending the equipment’s lifespan to realize maximum return on investment. One of the major factors for the growing demand for refurbished pharmaceutical manufacturing equipment in developing economies is the gap between demand and supply leading to limited accessibility of new equipment. Moreover, it becomes difficult for small and medium-sized pharmaceutical manufacturing plants to adopt and upgrade new equipment due to a limited purchasing budget. As a result, the global demand for refurbished pharmaceutical manufacturing equipment is increasing.
  • Opportunity:Adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages
  • Rapidly growing demand for drugs and injectables has triggered competition among manufacturers to expedite the development and review pathways to reduce the demand and supply gap. In the pharmaceutical industry, there are many first-to-market benefits spanning across different market contexts and are more evident in cases of specialty areas with a small number of patients and prescribers and when the first mover is a well-established pharmaceutical manufacturer with experience in the product’s therapeutic area. Traditionally, pharmaceutical manufacturing has been executed through a combination of multiple facilities to perform different processes across the supply chain. But, as the competition to increase the speed to market has intensified, the project delays occurring due to transfers between different manufacturing sites are negatively hampering the manufacturers. This emphasizes the utilization of modern and advanced pharmaceutical manufacturing equipment, especially in modular setups, to enable the manufacturing of pharmaceuticals from one single diverse facility encompassing all supply chain processes. The use of modern pharmaceutical manufacturing equipment is helping manufacturers to cut down on lead times.
  • Challenge: Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment
  • Pharmaceutical manufacturing equipment must comply with strict regulations and guidelines set by government agencies, such as the EMA and FDA. Adhering to multiple regulations and standards is a time-consuming process and increases capital expenditures. In addition, pharmaceutical manufacturing equipment is often expensive to purchase, operate, and maintain. The high upfront costs related to adherence to regulations and maintenance can hinder innovation and product development. They also threaten the entry of emerging or smaller players to enter the market. Moreover, to cater to the ever-changing market demand in the pharmaceutical industry, manufacturing equipment needs to be constantly evolving. It needs regular upgrades, which involves additional costs for pharmaceutical manufacturers. This poses a significant challenge for pharmaceutical players to adopt and maintain various pharmaceutical manufacturing equipment.
  • Packaging machines accounted for the largest share of the pharmaceutical manufacturing equipment market in 2022
  • The use of pharmaceutical packaging machines helps ensure that the final product is protected from contamination, damage, and degradation and meets the required specifications for labeling, dosage, and storage. The efficient and precise packaging of drug products is essential to ensure that they are safe and effective for patient use and to comply with regulatory requirements. With the increasing geriatric population, rising healthcare investment, and growing cases of chronic diseases across the world, the demand for diverse and innovative drugs is increasing, which in turn are driving the adoption of technologically advanced pharmaceutical packaging machines to adhere to the stringent regulatory policies.
  • Liquid end-product type segment to account for the largest share of the market during forecast period
  • Liquid dosage forms are easier to swallow and more suitable for patients with difficulty swallowing tablets or capsules. They allow precise dosing, as the amount of drug in each dose can be easily measured and adjusted. This is particularly important for drugs with a narrow therapeutic range or requiring precise dosing. Liquid dosage forms provide greater flexibility in formulation, as drugs that are insoluble or unstable in solid dosage forms can be formulated as solutions or suspensions. Owing to these reasons, liquid dosage forms are preferred more over solid dosage forms, thereby driving their demand.
  • Asia Pacific held for the largest share of the pharmaceutical manufacturing equipment market in 2022
  • Asia Pacific is one of the fastest-growing and dynamically emerging pharmaceutical markets globally. Due to the low labor and manufacturing costs, the developing pharmaceutical manufacturing infrastructure, especially in India and China, has attracted many foreign investments from several pharma giants such as Uhlmann Group, Bausch+Ströbel, IMA S.p.A., and Marchesini Group. Moreover, governments across Asia are implementing schemes to boost local manufacturing capacity, expand generic drug production, and enhance quality assurance by establishing stringent regulations to meet global standards.
  • Recent Developments
  • In January 2023, Romaco Group launched Unity 600 blister packaging line from the Romaco Noack brand. The new technology leads the way in sustainability, process reliability, and performance.
  • In September 2022, GEA Group Aktiengesellschaft launched an air heating system for spray dryers that reduces a plant’s consumption of fossil fuels and its associated carbon footprint by at least 50%.
  • In August 2022, GEA Group Aktiengesellschaft launched the NexGen Press, a new tablet press product line. This product line combines the advantages of existing products MODUL and PERFORMA rotary table press lines.
  • In July 2022, Marchesini Group along with SEA Vision Group (Italy) introduced a new serialization and aggregation technology INTEGRA 720V complete robotized blister line, the BL-A525 CW high-speed labeler, and the complete Track & Trace software solution developed by SEA Vision Group.
  • In September 2021, Syntegon Technology GmbH presents new solutions for lab-scale and small-batch filling of solid and liquid pharmaceuticals. The new GKF 60 capsule filling machine enables the development of new formulations with various dosing systems at different OEB levels and an optional 100% gravimetric weighing system.
  • KEY MARKET SEGMENTS
  • By Equipment Type:
  • Packaging Machines
  • Mixing and Blending Machines
  • Filling Machines
  • Spray Drying Equipment
  • Milling Equipment
  • Inspection Equipment
  • Extrusion Equipment
  • Tablet Compression Presses
  • By End-product Type:
  • Solid
  • Liquid
  • By Region
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Middle East & Africa
  • South America
  • KEY MARKET PLAYERS
  • GEA Group Aktiengesellschaft
  • I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A
  • Syntegon Technology GmbH
  • ACG
  • Thermo Fisher Scientific Inc.

SkyQuest's Expertise:

The Pharmaceutical Manufacturing Equipment Market is being analyzed by SkyQuest's analysts with the help of 20+ scheduled Primary interviews from both the demand and supply sides. We have already invested more than 250 hours on this report and are still refining our date to provide authenticated data to your readers and clients. Exhaustive primary and secondary research is conducted to collect information on the market, peer market, and parent market.

Our cross-industry experts and revenue-impact consultants at SkyQuest enable our clients to convert market intelligence into actionable, quantifiable results through personalized engagement.

Scope Of Report

Report Attribute Details
The base year for estimation 2021
Historical data 2016 – 2022
Forecast period 2022 – 2028
Report coverage Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis
Segments covered
  • By Equipment Type: - Packaging Machines, Mixing and Blending Machines, Filling Machines, Spray Drying Equipment, Milling Equipment, Inspection Equipment, Extrusion Equipment, Tablet Compression Presses
  • By End-product Type: - Solid, Liquid
  • By Region - North America, US, Canada, Mexico, Europe, Germany, UK, France, Italy, Rest of Europe, Asia Pacific, China, Japan, India, South Korea, Rest of Asia Pacific, Rest of the World, Middle East & Africa, South America, KEY MARKET PLAYERS, GEA Group Aktiengesellschaft, I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A, Syntegon Technology GmbH, ACG, Thermo Fisher Scientific Inc.
Regional scope North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA)
Country scope U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, South Africa
Key companies profiled
  • eutical manufacturing equipment market is estimated to be worth USD 14.5 billion in 2023 and is projected to reach USD 19.7 billion by 2028, at a CAGR of 6.3% during the forecast period. Growing global demand for generics, rising necessity for adoption of flexible pharmaceutical manufacturing practices, rising potential of pharmaceutical manufacturing infrastructure worldwide, and growing implementation of government schemes and regulatory frameworks for quality assurance are some of the major factors driving the market growth globally.
  • Pharmaceutical Manufacturing Equipment Market Dynamics
  • Driver: Rising demand for generics
  • As patents on branded drugs are expiring, the generic drug market is proliferating worldwide. One of the major factors driving the generic drug market is the implementation of favorable policy frameworks across regions aimed at reducing the overall cost of healthcare and check the spread of chronic diseases. In a time when pharmaceutical manufacturers are experiencing stagnation in developed economies, the growth opportunities in emerging markets, especially in Africa, seem enormous. Significant factors contributing to these opportunities include critical infrastructure improvements, extensive urbanization, rising demand for a diverse set of medications from the population, and growing investments in the healthcare sector. Moreover, there is a growing inclination toward injectable generics. Governments across the world are supporting the manufacturing of injectable generics as they offer benefits in terms of dosage, quality, strength, and less cost-intensive R&D cycle. Even in developed economies such as the US, the growing aging population, the expiration of patents for many popular drugs, and an exponential rise in chronic diseases are contributing to the growth of the generics market.
  • Restraint: Demand for refurbished equipment
  • For manufacturers to purchase and install new manufacturing equipment, many upfront costs are involved. In addition, manufacturing equipment can rapidly become outdated in a dynamic industry such as pharmaceuticals. Therefore, there is a growing demand for refurbished pharmaceutical manufacturing equipment across the globe. Refurbishment can be described as rebuilding or updating used equipment with new materials, technology, components, or parts to restore its condition to its original operating state and appearance. Moreover, refurbishment typically costs around half as much as acquiring new equipment. Therefore, refurbished manufacturing equipment helps the manufacturer by reducing upfront costs, providing flexibility for upgradation, and lessening costs by extending the equipment’s lifespan to realize maximum return on investment. One of the major factors for the growing demand for refurbished pharmaceutical manufacturing equipment in developing economies is the gap between demand and supply leading to limited accessibility of new equipment. Moreover, it becomes difficult for small and medium-sized pharmaceutical manufacturing plants to adopt and upgrade new equipment due to a limited purchasing budget. As a result, the global demand for refurbished pharmaceutical manufacturing equipment is increasing.
  • Opportunity:Adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages
  • Rapidly growing demand for drugs and injectables has triggered competition among manufacturers to expedite the development and review pathways to reduce the demand and supply gap. In the pharmaceutical industry, there are many first-to-market benefits spanning across different market contexts and are more evident in cases of specialty areas with a small number of patients and prescribers and when the first mover is a well-established pharmaceutical manufacturer with experience in the product’s therapeutic area. Traditionally, pharmaceutical manufacturing has been executed through a combination of multiple facilities to perform different processes across the supply chain. But, as the competition to increase the speed to market has intensified, the project delays occurring due to transfers between different manufacturing sites are negatively hampering the manufacturers. This emphasizes the utilization of modern and advanced pharmaceutical manufacturing equipment, especially in modular setups, to enable the manufacturing of pharmaceuticals from one single diverse facility encompassing all supply chain processes. The use of modern pharmaceutical manufacturing equipment is helping manufacturers to cut down on lead times.
  • Challenge: Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment
  • Pharmaceutical manufacturing equipment must comply with strict regulations and guidelines set by government agencies, such as the EMA and FDA. Adhering to multiple regulations and standards is a time-consuming process and increases capital expenditures. In addition, pharmaceutical manufacturing equipment is often expensive to purchase, operate, and maintain. The high upfront costs related to adherence to regulations and maintenance can hinder innovation and product development. They also threaten the entry of emerging or smaller players to enter the market. Moreover, to cater to the ever-changing market demand in the pharmaceutical industry, manufacturing equipment needs to be constantly evolving. It needs regular upgrades, which involves additional costs for pharmaceutical manufacturers. This poses a significant challenge for pharmaceutical players to adopt and maintain various pharmaceutical manufacturing equipment.
  • Packaging machines accounted for the largest share of the pharmaceutical manufacturing equipment market in 2022
  • The use of pharmaceutical packaging machines helps ensure that the final product is protected from contamination, damage, and degradation and meets the required specifications for labeling, dosage, and storage. The efficient and precise packaging of drug products is essential to ensure that they are safe and effective for patient use and to comply with regulatory requirements. With the increasing geriatric population, rising healthcare investment, and growing cases of chronic diseases across the world, the demand for diverse and innovative drugs is increasing, which in turn are driving the adoption of technologically advanced pharmaceutical packaging machines to adhere to the stringent regulatory policies.
  • Liquid end-product type segment to account for the largest share of the market during forecast period
  • Liquid dosage forms are easier to swallow and more suitable for patients with difficulty swallowing tablets or capsules. They allow precise dosing, as the amount of drug in each dose can be easily measured and adjusted. This is particularly important for drugs with a narrow therapeutic range or requiring precise dosing. Liquid dosage forms provide greater flexibility in formulation, as drugs that are insoluble or unstable in solid dosage forms can be formulated as solutions or suspensions. Owing to these reasons, liquid dosage forms are preferred more over solid dosage forms, thereby driving their demand.
  • Asia Pacific held for the largest share of the pharmaceutical manufacturing equipment market in 2022
  • Asia Pacific is one of the fastest-growing and dynamically emerging pharmaceutical markets globally. Due to the low labor and manufacturing costs, the developing pharmaceutical manufacturing infrastructure, especially in India and China, has attracted many foreign investments from several pharma giants such as Uhlmann Group, Bausch+Ströbel, IMA S.p.A., and Marchesini Group. Moreover, governments across Asia are implementing schemes to boost local manufacturing capacity, expand generic drug production, and enhance quality assurance by establishing stringent regulations to meet global standards.
  • Recent Developments
  • In January 2023, Romaco Group launched Unity 600 blister packaging line from the Romaco Noack brand. The new technology leads the way in sustainability, process reliability, and performance.
  • In September 2022, GEA Group Aktiengesellschaft launched an air heating system for spray dryers that reduces a plant’s consumption of fossil fuels and its associated carbon footprint by at least 50%.
  • In August 2022, GEA Group Aktiengesellschaft launched the NexGen Press, a new tablet press product line. This product line combines the advantages of existing products MODUL and PERFORMA rotary table press lines.
  • In July 2022, Marchesini Group along with SEA Vision Group (Italy) introduced a new serialization and aggregation technology INTEGRA 720V complete robotized blister line, the BL-A525 CW high-speed labeler, and the complete Track & Trace software solution developed by SEA Vision Group.
  • In September 2021, Syntegon Technology GmbH presents new solutions for lab-scale and small-batch filling of solid and liquid pharmaceuticals. The new GKF 60 capsule filling machine enables the development of new formulations with various dosing systems at different OEB levels and an optional 100% gravimetric weighing system.
  • KEY MARKET SEGMENTS
  • By Equipment Type:
  • Packaging Machines
  • Mixing and Blending Machines
  • Filling Machines
  • Spray Drying Equipment
  • Milling Equipment
  • Inspection Equipment
  • Extrusion Equipment
  • Tablet Compression Presses
  • By End-product Type:
  • Solid
  • Liquid
  • By Region
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Middle East & Africa
  • South America
  • KEY MARKET PLAYERS
  • GEA Group Aktiengesellschaft
  • I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A
  • Syntegon Technology GmbH
  • ACG
  • Thermo Fisher Scientific Inc.
Customization scope Free report customization (15% Free customization) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Reap the benefits of customized purchase options to fit your specific research requirements.

Objectives of the Study

  • To forecast the market size, in terms of value, for various segments with respect to five main regions, namely, North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA)
  • To provide detailed information regarding the major factors influencing the growth of the Market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micro markets with respect to the individual growth trends, future prospects, and contribution to the total market
  • To provide a detailed overview of the value chain and analyze market trends with the Porter's five forces analysis
  • To analyze the opportunities in the market for various stakeholders by identifying the high-growth Segments
  • To identify the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
  • To analyze competitive development such as joint ventures, mergers and acquisitions, new product launches and development, and research and development in the market

What does this Report Deliver?

  • Market Estimation for 20+ Countries
  • Historical data coverage: 2016 to 2022
  • Growth projections: 2022 to 2028
  • SkyQuest's premium market insights: Innovation matrix, IP analysis, Production Analysis, Value chain analysis, Technological trends, and Trade analysis
  • Customization on Segments, Regions, and Company Profiles
  • 100+ tables, 150+ Figures, 10+ matrix
  • Global and Country Market Trends
  • Comprehensive Mapping of Industry Parameters
  • Attractive Investment Proposition
  • Competitive Strategies Adopted by Leading Market Participants
  • Market drivers, restraints, opportunities, and its impact on the market
  • Regulatory scenario, regional dynamics, and insights of leading countries in each region
  • Segment trends analysis, opportunity, and growth
  • Opportunity analysis by region and country
  • Porter's five force analysis to know the market's condition
  • Pricing analysis
  • Parent market analysis
  • Product portfolio benchmarking

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Pharmaceutical Manufacturing Equipment Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Pharmaceutical Manufacturing Equipment Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)
  • eutical manufacturing equipment market is estimated to be worth USD 14.5 billion in 2023 and is projected to reach USD 19.7 billion by 2028, at a CAGR of 6.3% during the forecast period. Growing global demand for generics, rising necessity for adoption of flexible pharmaceutical manufacturing practices, rising potential of pharmaceutical manufacturing infrastructure worldwide, and growing implementation of government schemes and regulatory frameworks for quality assurance are some of the major factors driving the market growth globally.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Pharmaceutical Manufacturing Equipment Market Dynamics
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Driver: Rising demand for generics
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • As patents on branded drugs are expiring, the generic drug market is proliferating worldwide. One of the major factors driving the generic drug market is the implementation of favorable policy frameworks across regions aimed at reducing the overall cost of healthcare and check the spread of chronic diseases. In a time when pharmaceutical manufacturers are experiencing stagnation in developed economies, the growth opportunities in emerging markets, especially in Africa, seem enormous. Significant factors contributing to these opportunities include critical infrastructure improvements, extensive urbanization, rising demand for a diverse set of medications from the population, and growing investments in the healthcare sector. Moreover, there is a growing inclination toward injectable generics. Governments across the world are supporting the manufacturing of injectable generics as they offer benefits in terms of dosage, quality, strength, and less cost-intensive R&D cycle. Even in developed economies such as the US, the growing aging population, the expiration of patents for many popular drugs, and an exponential rise in chronic diseases are contributing to the growth of the generics market.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Restraint: Demand for refurbished equipment
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • For manufacturers to purchase and install new manufacturing equipment, many upfront costs are involved. In addition, manufacturing equipment can rapidly become outdated in a dynamic industry such as pharmaceuticals. Therefore, there is a growing demand for refurbished pharmaceutical manufacturing equipment across the globe. Refurbishment can be described as rebuilding or updating used equipment with new materials, technology, components, or parts to restore its condition to its original operating state and appearance. Moreover, refurbishment typically costs around half as much as acquiring new equipment. Therefore, refurbished manufacturing equipment helps the manufacturer by reducing upfront costs, providing flexibility for upgradation, and lessening costs by extending the equipment’s lifespan to realize maximum return on investment. One of the major factors for the growing demand for refurbished pharmaceutical manufacturing equipment in developing economies is the gap between demand and supply leading to limited accessibility of new equipment. Moreover, it becomes difficult for small and medium-sized pharmaceutical manufacturing plants to adopt and upgrade new equipment due to a limited purchasing budget. As a result, the global demand for refurbished pharmaceutical manufacturing equipment is increasing.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Opportunity:Adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Rapidly growing demand for drugs and injectables has triggered competition among manufacturers to expedite the development and review pathways to reduce the demand and supply gap. In the pharmaceutical industry, there are many first-to-market benefits spanning across different market contexts and are more evident in cases of specialty areas with a small number of patients and prescribers and when the first mover is a well-established pharmaceutical manufacturer with experience in the product’s therapeutic area. Traditionally, pharmaceutical manufacturing has been executed through a combination of multiple facilities to perform different processes across the supply chain. But, as the competition to increase the speed to market has intensified, the project delays occurring due to transfers between different manufacturing sites are negatively hampering the manufacturers. This emphasizes the utilization of modern and advanced pharmaceutical manufacturing equipment, especially in modular setups, to enable the manufacturing of pharmaceuticals from one single diverse facility encompassing all supply chain processes. The use of modern pharmaceutical manufacturing equipment is helping manufacturers to cut down on lead times.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Challenge: Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Pharmaceutical manufacturing equipment must comply with strict regulations and guidelines set by government agencies, such as the EMA and FDA. Adhering to multiple regulations and standards is a time-consuming process and increases capital expenditures. In addition, pharmaceutical manufacturing equipment is often expensive to purchase, operate, and maintain. The high upfront costs related to adherence to regulations and maintenance can hinder innovation and product development. They also threaten the entry of emerging or smaller players to enter the market. Moreover, to cater to the ever-changing market demand in the pharmaceutical industry, manufacturing equipment needs to be constantly evolving. It needs regular upgrades, which involves additional costs for pharmaceutical manufacturers. This poses a significant challenge for pharmaceutical players to adopt and maintain various pharmaceutical manufacturing equipment.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Packaging machines accounted for the largest share of the pharmaceutical manufacturing equipment market in 2022
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • The use of pharmaceutical packaging machines helps ensure that the final product is protected from contamination, damage, and degradation and meets the required specifications for labeling, dosage, and storage. The efficient and precise packaging of drug products is essential to ensure that they are safe and effective for patient use and to comply with regulatory requirements. With the increasing geriatric population, rising healthcare investment, and growing cases of chronic diseases across the world, the demand for diverse and innovative drugs is increasing, which in turn are driving the adoption of technologically advanced pharmaceutical packaging machines to adhere to the stringent regulatory policies.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Liquid end-product type segment to account for the largest share of the market during forecast period
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Liquid dosage forms are easier to swallow and more suitable for patients with difficulty swallowing tablets or capsules. They allow precise dosing, as the amount of drug in each dose can be easily measured and adjusted. This is particularly important for drugs with a narrow therapeutic range or requiring precise dosing. Liquid dosage forms provide greater flexibility in formulation, as drugs that are insoluble or unstable in solid dosage forms can be formulated as solutions or suspensions. Owing to these reasons, liquid dosage forms are preferred more over solid dosage forms, thereby driving their demand.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Asia Pacific held for the largest share of the pharmaceutical manufacturing equipment market in 2022
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Asia Pacific is one of the fastest-growing and dynamically emerging pharmaceutical markets globally. Due to the low labor and manufacturing costs, the developing pharmaceutical manufacturing infrastructure, especially in India and China, has attracted many foreign investments from several pharma giants such as Uhlmann Group, Bausch+Ströbel, IMA S.p.A., and Marchesini Group. Moreover, governments across Asia are implementing schemes to boost local manufacturing capacity, expand generic drug production, and enhance quality assurance by establishing stringent regulations to meet global standards.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Recent Developments
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In January 2023, Romaco Group launched Unity 600 blister packaging line from the Romaco Noack brand. The new technology leads the way in sustainability, process reliability, and performance.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In September 2022, GEA Group Aktiengesellschaft launched an air heating system for spray dryers that reduces a plant’s consumption of fossil fuels and its associated carbon footprint by at least 50%.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In August 2022, GEA Group Aktiengesellschaft launched the NexGen Press, a new tablet press product line. This product line combines the advantages of existing products MODUL and PERFORMA rotary table press lines.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In July 2022, Marchesini Group along with SEA Vision Group (Italy) introduced a new serialization and aggregation technology INTEGRA 720V complete robotized blister line, the BL-A525 CW high-speed labeler, and the complete Track & Trace software solution developed by SEA Vision Group.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In September 2021, Syntegon Technology GmbH presents new solutions for lab-scale and small-batch filling of solid and liquid pharmaceuticals. The new GKF 60 capsule filling machine enables the development of new formulations with various dosing systems at different OEB levels and an optional 100% gravimetric weighing system.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • KEY MARKET SEGMENTS
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • By Equipment Type:
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Packaging Machines
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Mixing and Blending Machines
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Filling Machines
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Spray Drying Equipment
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Milling Equipment
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Inspection Equipment
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Extrusion Equipment
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Tablet Compression Presses
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • By End-product Type:
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Solid
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Liquid
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • By Region
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • North America
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • US
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Canada
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Mexico
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Europe
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Germany
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • UK
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • France
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Italy
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Rest of Europe
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Asia Pacific
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • China
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Japan
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • India
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • South Korea
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Rest of Asia Pacific
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Rest of the World
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Middle East & Africa
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • South America
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • KEY MARKET PLAYERS
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • GEA Group Aktiengesellschaft
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Syntegon Technology GmbH
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • ACG
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Thermo Fisher Scientific Inc.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments

Methodology

For the Pharmaceutical Manufacturing Equipment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Pharmaceutical Manufacturing Equipment Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Pharmaceutical Manufacturing Equipment Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Pharmaceutical Manufacturing Equipment Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The global market for Pharmaceutical Manufacturing Equipment was estimated to be valued at US$ XX Mn in 2021.

The global Pharmaceutical Manufacturing Equipment Market is estimated to grow at a CAGR of XX% by 2028.

The global Pharmaceutical Manufacturing Equipment Market is segmented on the basis of Equipment Type:, End-product Type:, Region.

Based on region, the global Pharmaceutical Manufacturing Equipment Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the global Pharmaceutical Manufacturing Equipment Market are eutical manufacturing equipment market is estimated to be worth USD 14.5 billion in 2023 and is projected to reach USD 19.7 billion by 2028, at a CAGR of 6.3% during the forecast period. Growing global demand for generics, rising necessity for adoption of flexible pharmaceutical manufacturing practices, rising potential of pharmaceutical manufacturing infrastructure worldwide, and growing implementation of government schemes and regulatory frameworks for quality assurance are some of the major factors driving the market growth globally. , Pharmaceutical Manufacturing Equipment Market Dynamics , Driver: Rising demand for generics , As patents on branded drugs are expiring, the generic drug market is proliferating worldwide. One of the major factors driving the generic drug market is the implementation of favorable policy frameworks across regions aimed at reducing the overall cost of healthcare and check the spread of chronic diseases. In a time when pharmaceutical manufacturers are experiencing stagnation in developed economies, the growth opportunities in emerging markets, especially in Africa, seem enormous. Significant factors contributing to these opportunities include critical infrastructure improvements, extensive urbanization, rising demand for a diverse set of medications from the population, and growing investments in the healthcare sector. Moreover, there is a growing inclination toward injectable generics. Governments across the world are supporting the manufacturing of injectable generics as they offer benefits in terms of dosage, quality, strength, and less cost-intensive R&D cycle. Even in developed economies such as the US, the growing aging population, the expiration of patents for many popular drugs, and an exponential rise in chronic diseases are contributing to the growth of the generics market. , Restraint: Demand for refurbished equipment , For manufacturers to purchase and install new manufacturing equipment, many upfront costs are involved. In addition, manufacturing equipment can rapidly become outdated in a dynamic industry such as pharmaceuticals. Therefore, there is a growing demand for refurbished pharmaceutical manufacturing equipment across the globe. Refurbishment can be described as rebuilding or updating used equipment with new materials, technology, components, or parts to restore its condition to its original operating state and appearance. Moreover, refurbishment typically costs around half as much as acquiring new equipment. Therefore, refurbished manufacturing equipment helps the manufacturer by reducing upfront costs, providing flexibility for upgradation, and lessening costs by extending the equipment’s lifespan to realize maximum return on investment. One of the major factors for the growing demand for refurbished pharmaceutical manufacturing equipment in developing economies is the gap between demand and supply leading to limited accessibility of new equipment. Moreover, it becomes difficult for small and medium-sized pharmaceutical manufacturing plants to adopt and upgrade new equipment due to a limited purchasing budget. As a result, the global demand for refurbished pharmaceutical manufacturing equipment is increasing. , Opportunity:Adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages , Rapidly growing demand for drugs and injectables has triggered competition among manufacturers to expedite the development and review pathways to reduce the demand and supply gap. In the pharmaceutical industry, there are many first-to-market benefits spanning across different market contexts and are more evident in cases of specialty areas with a small number of patients and prescribers and when the first mover is a well-established pharmaceutical manufacturer with experience in the product’s therapeutic area. Traditionally, pharmaceutical manufacturing has been executed through a combination of multiple facilities to perform different processes across the supply chain. But, as the competition to increase the speed to market has intensified, the project delays occurring due to transfers between different manufacturing sites are negatively hampering the manufacturers. This emphasizes the utilization of modern and advanced pharmaceutical manufacturing equipment, especially in modular setups, to enable the manufacturing of pharmaceuticals from one single diverse facility encompassing all supply chain processes. The use of modern pharmaceutical manufacturing equipment is helping manufacturers to cut down on lead times. , Challenge: Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment , Pharmaceutical manufacturing equipment must comply with strict regulations and guidelines set by government agencies, such as the EMA and FDA. Adhering to multiple regulations and standards is a time-consuming process and increases capital expenditures. In addition, pharmaceutical manufacturing equipment is often expensive to purchase, operate, and maintain. The high upfront costs related to adherence to regulations and maintenance can hinder innovation and product development. They also threaten the entry of emerging or smaller players to enter the market. Moreover, to cater to the ever-changing market demand in the pharmaceutical industry, manufacturing equipment needs to be constantly evolving. It needs regular upgrades, which involves additional costs for pharmaceutical manufacturers. This poses a significant challenge for pharmaceutical players to adopt and maintain various pharmaceutical manufacturing equipment. , Packaging machines accounted for the largest share of the pharmaceutical manufacturing equipment market in 2022 , The use of pharmaceutical packaging machines helps ensure that the final product is protected from contamination, damage, and degradation and meets the required specifications for labeling, dosage, and storage. The efficient and precise packaging of drug products is essential to ensure that they are safe and effective for patient use and to comply with regulatory requirements. With the increasing geriatric population, rising healthcare investment, and growing cases of chronic diseases across the world, the demand for diverse and innovative drugs is increasing, which in turn are driving the adoption of technologically advanced pharmaceutical packaging machines to adhere to the stringent regulatory policies. , Liquid end-product type segment to account for the largest share of the market during forecast period , Liquid dosage forms are easier to swallow and more suitable for patients with difficulty swallowing tablets or capsules. They allow precise dosing, as the amount of drug in each dose can be easily measured and adjusted. This is particularly important for drugs with a narrow therapeutic range or requiring precise dosing. Liquid dosage forms provide greater flexibility in formulation, as drugs that are insoluble or unstable in solid dosage forms can be formulated as solutions or suspensions. Owing to these reasons, liquid dosage forms are preferred more over solid dosage forms, thereby driving their demand. , Asia Pacific held for the largest share of the pharmaceutical manufacturing equipment market in 2022 , Asia Pacific is one of the fastest-growing and dynamically emerging pharmaceutical markets globally. Due to the low labor and manufacturing costs, the developing pharmaceutical manufacturing infrastructure, especially in India and China, has attracted many foreign investments from several pharma giants such as Uhlmann Group, Bausch+Ströbel, IMA S.p.A., and Marchesini Group. Moreover, governments across Asia are implementing schemes to boost local manufacturing capacity, expand generic drug production, and enhance quality assurance by establishing stringent regulations to meet global standards. , Recent Developments , In January 2023, Romaco Group launched Unity 600 blister packaging line from the Romaco Noack brand. The new technology leads the way in sustainability, process reliability, and performance. , In September 2022, GEA Group Aktiengesellschaft launched an air heating system for spray dryers that reduces a plant’s consumption of fossil fuels and its associated carbon footprint by at least 50%. , In August 2022, GEA Group Aktiengesellschaft launched the NexGen Press, a new tablet press product line. This product line combines the advantages of existing products MODUL and PERFORMA rotary table press lines. , In July 2022, Marchesini Group along with SEA Vision Group (Italy) introduced a new serialization and aggregation technology INTEGRA 720V complete robotized blister line, the BL-A525 CW high-speed labeler, and the complete Track & Trace software solution developed by SEA Vision Group. , In September 2021, Syntegon Technology GmbH presents new solutions for lab-scale and small-batch filling of solid and liquid pharmaceuticals. The new GKF 60 capsule filling machine enables the development of new formulations with various dosing systems at different OEB levels and an optional 100% gravimetric weighing system. , KEY MARKET SEGMENTS , By Equipment Type: , Packaging Machines , Mixing and Blending Machines , Filling Machines , Spray Drying Equipment , Milling Equipment , Inspection Equipment , Extrusion Equipment , Tablet Compression Presses , By End-product Type: , Solid , Liquid , By Region , North America , US , Canada , Mexico , Europe , Germany , UK , France , Italy , Rest of Europe , Asia Pacific , China , Japan , India , South Korea , Rest of Asia Pacific , Rest of the World , Middle East & Africa , South America , KEY MARKET PLAYERS , GEA Group Aktiengesellschaft , I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A , Syntegon Technology GmbH , ACG , Thermo Fisher Scientific Inc..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Pharmaceutical Manufacturing Equipment Market

Report ID: SQSG35J2004 | Region: Global | Published Date: Upcoming | Pages: 247 | Tables: 55 | Figures: 60

Global Industrial Enzymes Market
Buy Now GET FREE SAMPLE
Pharmaceutical Manufacturing Equipment Market

Report ID: UCMIR35J2141 | Region: Regional | Published Date: Upcoming | Pages: 165 | Tables: 55 | Figures: 60

Europe AI In Life Science Analytics Market
Buy Now GET FREE SAMPLE
Pharmaceutical Manufacturing Equipment Market

Report ID: UCMIG35J2098 | Region: Global | Published Date: Upcoming | Pages: 165 | Tables: 55 | Figures: 60

Oncology Based In-vivo CRO Market
Buy Now GET FREE SAMPLE
Pharmaceutical Manufacturing Equipment Market

Report ID: UCMIG35J2042 | Region: Global | Published Date: Upcoming | Pages: 165 | Tables: 55 | Figures: 60

Smart Home Healthcare Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Pharmaceutical Manufacturing Equipment Market

Product ID: UCMIG35J2138

$5,300
BUY NOW GET FREE SAMPLE